With Blindsight now receiving the FDA’s Breakthrough Device Designation, Neuralink looks set to push forward with technology ...

Neuralink's N1 device, aiming to restore mobility and vision, could impact millions. Neuralink is not publicly traded, limiting direct investment opportunities. Invest indirectly via Alphabet ...

The Precise Robotically Implanted Brain-Computer Interface (PRIME) study will evaluate the safety of Neuralink's implant (N1) ...

Elon Musk’s brain chip firm Neuralink has received “breakthrough device” status for an implant aimed at helping blind patients regain their sight, the firm announced. Dubbed “Blindsight ...

Sept 17 (Reuters) - Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough ...

Neuralink, the Elon Musk-owned brain-computer interface company, on Tuesday received “breakthrough device” clearance from the FDA. But this does not mean the outfit has developed a cure for ...

Elon Musk's brain-chip startup Neuralink said on Tuesday its experimental implant aimed at restoring vision received the U.S. Food and Drug Administration's "breakthrough device" designation.

Elon Musk's Neuralink has been granted the FDA's breakthrough device designation for its vision implant, Blindsight. This technology aims to restore sight for those who have lost it or were born ...